AFS
WST icon

Annapolis Financial Services’s West Pharmaceutical WST Stock Holding History

Annapolis Financial Services’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$13.8K Hold
46
– – ﹤0.01% 261
2024
Q2 		$15.2K Hold
46
– – ﹤0.01% 248
2024
Q1 		$18.2K Hold
46
– – 0.01% 226
2023
Q4 		$16.2K Hold
46
– – ﹤0.01% 302
2023
Q3 		$17.3K Hold
46
– – 0.01% 282
2023
Q2 		$17.6K Hold
46
– – 0.01% 284
2023
Q1 		$15.9K Hold
46
– – ﹤0.01% 268
2022
Q4 		$10.8K Sell
46
-28
-38% -$6.63K ﹤0.01% 302
2022
Q3 		$18K Buy
+74
New +$22.5K 0.01% 272

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Annapolis Financial Services's WST Position: Q3 2024 in Review

Annapolis Financial Services held its West Pharmaceutical (WST) position steady in Q3 2024 at 46 shares worth $13.8K. The position accounts for ﹤0.01% of the portfolio, ranked #261.

Annapolis Financial Services first reported a position in WST in Q3 2022 and has held it in 9 quarters since. The position peaked at $18.2K in Q1 2024. 729 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Annapolis Financial Services held 46 shares of West Pharmaceutical worth $13.8K as of Q3 2024.
  • Annapolis Financial Services left its West Pharmaceutical share count unchanged in Q3 2024.
  • West Pharmaceutical made up ﹤0.01% of Annapolis Financial Services's portfolio in Q3 2024, its #261 holding.
  • Annapolis Financial Services first reported a position in West Pharmaceutical in Q3 2022 and has held it in 9 quarters since.
  • Annapolis Financial Services's West Pharmaceutical position peaked at $18.2K in Q1 2024.
  • 729 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Annapolis Financial Services's 13F filing for Q3 2024, filed 16 Oct 2024.